NCT04595045View on ClinicalTrials.gov

Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

July 28, 2022

Study Completion Date

July 28, 2022

Conditions
Multiple Sclerosis
Interventions
DRUG

Botulinum toxin type A infiltrations

Echo-guided infiltration of botulinum toxin type A (Dysport®) in the lower limbs according to normal service practice

Trial Locations (2)

28006

Hospital Universitario de la Princesa, Madrid

28220

Hospital Universitario Puerta de Hierro, Majadahonda

All Listed Sponsors
lead

Aránzazu Vázquez Doce

OTHER

NCT04595045 - Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis | Biotech Hunter | Biotech Hunter